Skip to content

Clinical trials

Phase 2/3 Anxiety Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anxiety Disorders Phase: Phase 2/3 Country / region: United States Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20023
20031
20042
20052
20081
20101
20111
20121
20161
20181
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Active, not recruiting2
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Duke University4
M.D. Anderson Cancer Center2
National Center for Complementary and Integrative Health (NCCIH)2
University of Pittsburgh2
Baylor College of Medicine1
Boston Medical Center1
Cedars-Sinai Medical Center1
Connor, Kathryn M., M.D.1
John V. Campo, M.D.1
Massachusetts General Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anxiety Disorders21
Generalized Anxiety Disorder4
Stress Disorders, Post-Traumatic4
Panic Disorder3
Fatigue2
Obsessive-Compulsive Disorder2
Phobia, Social2
Abdominal Pain1
Alcohol-Related Disorders1
Alcoholism1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.